SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
| [X] |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended July 27, 2003 or
| [ ] |
TRANSITION REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from_____________to______________.
0-21488
(Commission File Number)
CATALYST SEMICONDUCTOR, INC.
| Delaware (State or other jurisdiction of incorporation or organization) |
77-0083129 (I.R.S. Employer Identification No.) |
| 1250 Borregas Avenue | ||
| Sunnyvale, California (Address of Registrants principal executive offices) |
94089 (Zip Code) |
(408) 542-1000
(Registrants telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the Registrant in an accelerated filers (as defined in Rule 12(b)(2) of the Exchange Act). Yes o No x
The number of shares outstanding of the Registrants Common Stock as of August 18, 2003 was 16,428,666 exclusive of 3,044,100 shares of treasury stock.
CATALYST SEMICONDUCTOR, INC.
TABLE OF CONTENTS
| Page | ||||
PART I. |
FINANCIAL INFORMATION |
|||
Item 1. |
Consolidated Financial Statements |
|||
Unaudited Condensed Consolidated Balance Sheets
at July 31, 2003 and April 30, 2003
|
3 |
|||
Unaudited Condensed Consolidated Statements of Operations for the three
month periods ended July 31, 2003 and 2002
|
4 |
|||
Unaudited Condensed Consolidated Statements of Cash Flows for the three
month periods ended July 31, 2003 and 2002
|
5 |
|||
Notes to Unaudited Condensed Consolidated Financial Statements
|
6 |
|||
Item 2. |
Managements Discussion and Analysis of Financial Condition and
Results of Operations
|
12 |
||
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk
|
26 |
||
Item 4. |
Controls and Procedures
|
26 |
||
PART II. |
OTHER INFORMATION |
|||
Item 1. |
Legal Proceedings
|
27 |
||
Item 6. |
Exhibits and Reports on Form 8-K
|
27 |
||
SIGNATURES |
28 | |||
EXHIBIT
INDEX |
||||
CERTIFICATIONS |
||||
2
PART I FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
| July 31, | April 30, | |||||||||
| 2003 | 2003 | |||||||||
ASSETS |
||||||||||
Current assets: |
||||||||||
Cash and cash equivalents |
$ | 6,404 | $ | 7,828 | ||||||
Short term investments |
22,549 | 20,078 | ||||||||
Accounts receivable, net |
9,409 | 7,863 | ||||||||
Inventories, net |
7,537 | 8,423 | ||||||||
Deferred tax assets |
1,914 | 1,914 | ||||||||
Other assets |
1,045 | 1,146 | ||||||||
Total current assets |
48,858 | 47,252 | ||||||||
Property and equipment, net |
3,086 | 3,091 | ||||||||
Other assets |
286 | 245 | ||||||||
Total assets |
$ | 52,230 | $ | 50,588 | ||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||||
Current liabilities: |
||||||||||
Accounts payable |
$ | 3,998 | $ | 3,674 | ||||||
Accounts payablerelated parties |
37 | 18 | ||||||||
Accrued expenses |
2,723 | 3,126 | ||||||||
Deferred gross profit on shipments to distributors |
1,993 | 1,417 | ||||||||
Total current liabilities |
8,751 | 8,235 | ||||||||
Commitments and Contingencies (Note 8) |
||||||||||
Stockholders equity: |
||||||||||
Preferred stock, $.001 par value, 2,000 shares authorized;
no shares issued or outstanding |
| | ||||||||
Common stock, $.001 par value, 45,000 shares authorized;
19,473 issued and 16,429 outstanding at July 31, 2003
and 19,247 shares issued and 16,285 outstanding at April 30, 2003 |
19 | 19 | ||||||||
Additional paid in capital |
53,060 | 52,632 | ||||||||
Treasury stock, 3,044 at July 31, 2003 and 2,970 at April 30, 2003 |
(8,555 | ) | (8,340 | ) | ||||||
Accumulated deficit |
(1,065 | ) | (1,985 | ) | ||||||
Accumulated other comprehensive income |
20 | 27 | ||||||||
Total stockholders equity |
43,479 | 42,353 | ||||||||
Total liabilities and stockholders equity |
$ | 52,230 | $ | 50,588 | ||||||
See accompanying notes to the unaudited condensed consolidated financial statements.
3
CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
| Three Months Ended | |||||||||
| July 31, | July 31, | ||||||||
| 2003 | 2002 | ||||||||
Net revenues |
$ | 13,847 | $ | 12,457 | |||||
Cost of revenues |
8,700 | 7,019 | |||||||
Gross profit |
5,147 | 5,438 | |||||||
Research and development |
1,548 | 1,290 | |||||||
Selling, general and administrative |
2,607 | 2,359 | |||||||
Income from operations |
992 | 1,789 | |||||||
Interest income, net |
90 | 66 | |||||||
Income before income taxes |
1,082 | 1,855 | |||||||
Income tax provision |
162 | 695 | |||||||
Net income |
$ | 920 | $ | 1,160 | |||||
Net income per share: |
|||||||||
Basic |
$ | 0.06 | $ | 0.07 | |||||
Diluted |
$ | 0.05 | $ | 0.06 | |||||
Weighted average common shares: |
|||||||||
Basic |
16,358 | 16,926 | |||||||
Diluted |
18,755 | 18,958 | |||||||
See accompanying notes to the unaudited condensed consolidated financial statements.
4
CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| Three Months Ended | ||||||||||||
| July 31, | July 31, | |||||||||||
| 2003 | 2002 | |||||||||||
Cash flows from operating activities: |
||||||||||||
Net income |
$ | 920 | $ | 1,160 | ||||||||
Adjustments to reconcile net income to net cash provided by
operating activities: |
||||||||||||
Depreciation of property and equipment |
321 | 245 | ||||||||||
Benefit from sale of inventory previously reserved |
(744 | ) | (1,130 | ) | ||||||||
Provision for excess and obsolete inventory |
375 | 1,028 | ||||||||||
Changes in assets and liabilities: |
||||||||||||
Accounts receivable |
(1,546 | ) | 693 | |||||||||
Inventories |
1,255 | (352 | ) | |||||||||
Other assets |
60 | (369 | ) | |||||||||
Accounts payable (including related parties) |
343 | (614 | ) | |||||||||
Accrued expenses |
(238 | ) | 826 | |||||||||
Deferred gross profit on shipments to distributors |
576 | 97 | ||||||||||
Net cash provided by operating activities |
1,322 | 1,584 | ||||||||||
Cash flows from investing activities: |
||||||||||||
Purchase of short-term investments |
(2,478 | ) | | |||||||||
Acquisition of property and equipment |
(316 | ) | (320 | ) | ||||||||
Net cash used in investing activities |
(2,794 | ) | (320 | ) | ||||||||
Cash flows from financing activities: |
||||||||||||
Common stock issuances |
263 | 99 | ||||||||||
Treasury stock purchases |
(215 | ) | (902 | ) | ||||||||
Net cash provided by (used in) financing activities |
48 | (803 | ) | |||||||||
Net increase (decrease) in cash and cash equivalents |
(1,424 | ) | 461 | |||||||||
Cash at beginning of the period |
7,828 | 26,295 | ||||||||||
Cash at end of the period |
$ | 6,404 | $ | 26,756 | ||||||||
Supplemental cash flow disclosures: |
||||||||||||
Income taxes |
$ | | $ | 6 | ||||||||
See accompanying notes to the unaudited condensed consolidated financial statements.
5
CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1 - Basis of Presentation:
In the opinion of the management of Catalyst Semiconductor, Inc. (Company), the unaudited condensed consolidated interim financial statements included herein have been prepared on the same basis as the April 30, 2003 audited consolidated financial statements and include all adjustments, consisting of only normal recurring adjustments, necessary to fairly state the information set forth herein. The consolidated statements include the accounts of the Companys wholly owned subsidiaries, Nippon Catalyst KK, a sales organization in Japan and Catalyst Semiconductor Romania Com SRL, a design center in Europe. All material intercompany balances have been eliminated. The statements have been prepared in accordance with the regulations of the Securities and Exchange Commission (SEC). For further information, refer to the consolidated financial statements and footnotes thereto included in the Companys Annual Report on Form 10-K for the year ended April 30, 2003. The results of operations for the three month period ended July 31, 2003 are not necessarily indicative of the results to be expected for the entire year ending April 30, 2004 or any other future period. Certain prior period balances have been reclassified to conform to the current period presentation.
The Companys business is highly cyclical and has been subject to significant downturns at various times which have been characterized by reduced product demand, production overcapacity and significant erosion of average selling prices.
The Companys fiscal year and its first, second and third fiscal quarters end on the Sunday closest to April 30, July 31, October 31 and January 31, respectively. For purposes of financial statement presentation, the year end date is expressed as April 30 and the quarter end dates are expressed as July 31, October 31 and January 31, respectively.
Comprehensive income is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. Through July 31, 2003, the Company had $20,000 of other comprehensive income resulting from unrealized gains from its treasury investment activities. Comprehensive expense for the quarter ended July 31, 2003 amounted to $7,000.
In December 2002, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 148, Accounting for Stock-Based Compensation, Transition and Disclosure which amended SFAS No. 123 (SFAS 123) requiring that disclosures of the pro forma effect use the fair value method of accounting for stock-based employee compensation be displayed more prominently, in a tabular format and on a quarterly basis. The following table illustrates the effect on the Companys net income and net income per share if compensation costs had been recorded based on the estimated fair value as of the grant date as defined by SFAS 123 for all granted stock-based awards.
| Three Months Ended | ||||||||
| July 31, | July 31, | |||||||
| 2003 | 2002 | |||||||
| (In thousands, except per share amounts) | ||||||||
Reported net income |
$ | 920 | $ | 1,160 | ||||
Add: Stock-based employee compensation expense included in
reported net income, net of
tax |
| 28 | ||||||
Deduct: Stock-based employee compensation expense determined
under fair value based method for all awards, net of
tax |
(748 | ) | (769 | ) | ||||
Pro forma net
income
|
$ | 172 | $ | 419 | ||||
Pro forma net income per share: |
||||||||
Basic |
$ | 0.01 | $ | 0.02 | ||||
Diluted |
$ | 0.01 | $ | 0.02 | ||||
Note 2 Net Income Per Share:
Basic net income per share is computed by dividing net income available to common stockholders (numerator) by the weighted average number of common shares outstanding (denominator) during the period and excludes the dilutive effect of stock options. Diluted net income per share gives effect to all dilutive potential common shares
6
outstanding during a period. In computing diluted net income per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options.
A reconciliation of the numerators and denominators of the basic and diluted income per share is presented in the following table (in thousands, except per share data):
| Three Months Ended | |||||||||
| July 31, | July 31, | ||||||||
| 2003 | 2002 | ||||||||
Reported net income |
$ | 920 | $ | 1,160 | |||||
Shares calculation: |
|||||||||
Weighted average shares outstandingbasic |
16,358 | 16,926 | |||||||
Effect of dilutive securities: |
|||||||||
Stock options |
2,397 | 2,032 | |||||||
Weighted average shares outstandingdiluted |
18,755 | 18,958 | |||||||
Reported net income per share: |
|||||||||
Basic |
$ | 0.06 | $ | 0.07 | |||||
Diluted |
$ | 0.05 | $ | 0.06 | |||||
Options to purchase 1,153,000 shares of Common Stock at prices from $4.07 to $9.50 per share outstanding during the quarter ended July 31, 2003 and options to purchase 1,673,000 shares of Common Stock at prices from $4.07 to $9.50 per share outstanding during the quarter ended July 31, 2002 were not included in the computation of diluted income per share because the inclusion of such options would have been antidilutive.
Note 3 Comprehensive Income:
The components of comprehensive income are presented in the following table (in thousands):
| Three Months Ended | ||||||||
| July 31, | July 31, | |||||||
| 2003 | 2002 | |||||||
Reported net income |
$ | 920 | $ | 1,160 | ||||
Other comprehensive income: |
||||||||
Unrealized losses on available-for-sale investments |
(7 | ) | | |||||
Total comprehensive income |
$ | 913 | $ | 1,160 | ||||
Accumulated other comprehensive income, as presented on the accompanying condensed consolidated balance sheets, consists of the unrealized loss on the available-for-sale investments.
Note 4 Balance Sheet Components (in thousands):
| July 31, 2003 | |||||||||||||
| Gross | |||||||||||||
| Unrealized | |||||||||||||
| Gains or | Estimated | ||||||||||||
| Cost | (Losses) | FMV | |||||||||||
Short-term investments: |
|||||||||||||
U.S. government debt securities with maturities less than one year |
$ | 19,127 | $ | 23 | $ | 19,150 | |||||||
U.S. government debt securities with maturities over one year |
3,402 | (3 | ) | 3,399 | |||||||||
Total short-term investments |
$ | 22,529 | $ | 20 | $ | 22,549 | |||||||
7
| April 30, 2003 | ||||||||||||||
| Gross | ||||||||||||||
| Unrealized | Estimated | |||||||||||||
| Cost | Gains | FMV | ||||||||||||
Short-term investments: |
||||||||||||||
U.S. government debt securities with maturities less than one year |
$ | 17,442 | $ | 23 | $ | 17,465 | ||||||||
U.S. government debt securities with maturities over one year |
2,609 | 4 | 2,613 | |||||||||||
Total short-term investments |
$ | 20,051 | $ | 27 | $ | 20,078 | ||||||||
| July 31, | April 30, | ||||||||
| 2003 | 2003 | ||||||||
Accounts receivable: |
|||||||||
Accounts receivable |
$ | 9,634 | $ | 8,088 | |||||
Less: Allowance for doubtful accounts |
(225 | ) | (225 | ) | |||||
| $ | 9,409 | $ | 7,863 | ||||||
Inventories: |
|||||||||
Work-in-process |
$ | 5,004 | $ | 6,487 | |||||
Finished goods |
2,533 | 1,936 | |||||||
| $ | 7,537 | $ | 8,423 | ||||||
Property and equipment: |
|||||||||
Engineering and test equipment |
$ | 6,840 | $ | 6,552 | < | ||||